Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;121(23-24):732-44.
doi: 10.1007/s00508-009-1288-2.

Innate immune dysfunction in acute and chronic liver disease

Affiliations
Review

Innate immune dysfunction in acute and chronic liver disease

Bettina Leber et al. Wien Klin Wochenschr. 2009.

Abstract

Liver cirrhosis is a common disease causing great public-health concern because of the frequent complications requiring hospital care. Acute liver failure is also prone to several complications but is rare. One of the main complications for both acute and chronic liver diseases is infection, which regularly causes decompensation of cirrhosis, possibly leading to organ failure and death. This review focuses on innate immune function in cirrhosis, acute-on-chronic liver failure and acute liver failure. The known defects of Kupffer cells, neutrophils and monocytes are discussed, together with the pathophysiological importance of gut permeability, portal hypertension and intrinsic cellular defects, and the role of endotoxin, albumin, lipoproteins and toll-like receptors. Based on these different pathomechanisms, the available information on therapeutic strategies is presented. Antibiotic and probiotic treatment, nutritional support, artificial liver support, and experimental strategies such as inhibition of toll-like receptors and use of albumin and colony-stimulating factors are highlighted.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):172S-179S - PubMed
    1. Semin Liver Dis. 2008 Feb;28(1):96-109 - PubMed
    1. J Immunol. 1993 Aug 1;151(3):1637-45 - PubMed
    1. Curr Med Chem. 2006;13(21):2487-502 - PubMed
    1. J Clin Invest. 1981 Mar;67(3):827-37 - PubMed

LinkOut - more resources